But how can it happen Reilly ?
RM is a trained researcher (PhD) who initially considered poh biggest problem one of technical credibility due to the 'work' of convicted frauds Ogru and Gianello. His plan to validate the science was applauded by every analyst and advisor I spoke to . Poh claim of achieving therapeutic levels with oxym' was an obvious candidate as was a tocopheryl phosphate comparison study to show tpm as pharma's premium choice. Having validated the relevant data all naysayers would hold their breath inc' yours truly.
But what happened to quell the critics and a SP similar to a skateboarder down a lift well ? Nothing !!!
I firmly believed RM wanted to achieve these goals but technically this couldn't be achieved , perhaps they tried but their peers rejected their effort.
So now we have the apparent situation of a failed reformer and the opinion by the market that the science doesn't stack up well underscored by a pitiful sp .
But what of Terumo? Most pharma and medical coys during the pdt development phase conduct comparisons with various components of that development . I'd suggest in this case tocopheryl phosphate. This time tpm was ironically brought to their attention by the Mylan debacle and the lack of any comparison studies imo . If you developing an expensive pdt you have to cover all bases and Terumo's payment and apparent silence appears consistent with this .
Ross may be a good scientist but he's not a magician
All in my opinion of course
- Forums
- ASX - By Stock
- The silence......
But how can it happen Reilly ? RM is a trained researcher (PhD)...
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $15.84M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $189.4K | 37.93M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 96459006 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 44667162 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 96459006 | 0.004 |
38 | 85474980 | 0.003 |
18 | 64435176 | 0.002 |
10 | 11005012 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 44667162 | 21 |
0.006 | 27552675 | 17 |
0.007 | 11272721 | 10 |
0.008 | 5987459 | 6 |
0.009 | 1840000 | 3 |
Last trade - 16.10pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.001 ( 11.1 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 18998000 | ||
Last updated 15.25pm 29/03/2024 ? |
Featured News
AVE (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online